|Bid||0.01 x 1400|
|Ask||19.28 x 800|
|Day's Range||17.23 - 17.69|
|52 Week Range||13.05 - 23.25|
|Beta (5Y Monthly)||1.02|
|PE Ratio (TTM)||18.80|
|Earnings Date||Nov 02, 2022 - Nov 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Oct 07, 2008|
|1y Target Est||21.60|
Subscribe to Yahoo Finance Plus to view Fair Value for MDRX
MDRX vs. OMCL: Which Stock Is the Better Value Option?
The average of price targets set by Wall Street analysts indicates a potential upside of 26.9% in AllScripts (MDRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Allscripts' (MDRX) robust Q2 results demonstrate strength in both segments.